149 / 510
Cuidados
Continuos
148
BIBLIOGRAFÍA
Montassier E, Batard E, Gastinne T, et al. Recent changes in bacteremia in patients with
cancer: a systematic review of epidemiology and antibiotic resistance. Eur J Clin Microbiol
Infect Dis 2013 32 (7): 841-850.
Kamana M, Escalante C, Mullen CA, et al. Bacterial infections in low –risk, febrile neutropenic
patients. Cancer 2005; 104:422
Bodey GP, Jadeja L, Elting L. Pseudomonas bacteremia. Retrospective analysis of 410 episodes.
Arch Intern Med 1985; 145:1621.
Montassier E, Batard E, Gastinne T et al. Recent changess in bacteriemia in patients with
cáncer: a systematic review of epidemiolgy and antibiotic resistance. Eur J Clin Microbiol
Infect Dis (2013) 32:841-850
Gudiol C, Bodro M, Simonetti A et al. Changing aetiology, clinical features, antimicrobial
resistance, and outcomes of bloodstream infection in neutropenic cáncer patients. Clin
Microbiol Infect 2013 May;19(5):474-9.
Freifeld AG, Bow EJ, Sepkowitz KA, et al. Clinical practice guideline for the use of antimicrobial
agents in neutropenic patients with cancer: 2010 update by the infectious diseases society of
america. Clin Infect Dis 2011 15; 52 (4):e56-93
Talcott JA, Siegel RD, Finberg et al (1992) Risk assesment in cáncer patients with fever and
neutropenia: a prospective, two-center validation of a prediction rule. J Clin Oncol 10:316-322.
Talcott JA, Whalen A, Clark J. Et al (1994) Home antibiotic therapy for low risk cáncer patients
with fever and neutropenia. J Clin Oncol 12:107-114.
Klastersky J, Paesmans M, Rubenstein EB et al (2000) The multinational association for
supportive care in cancer risk index: a multinational scoring system for identiying low-risk
febrile neutropenic cancer patients. J Clin Oncol 18:3038-3051.
Pun Hui E, Leung KS, Poon T et al (2011) Prediction of outcome in cancer patients with febrile
neutropenia: a prospective validation of the Multinational Association for supportive care in
cancer risk index un a Chinese population and comparison with the Talcott model and artificial
neural network. Support care cancer 19:1625-1635.
Carmona- Boyas A, Gómez J, Gónzalez-Billalaitia E et al (2011) Prognostic evaluation of febrile
neutropenia in apparently stable adult cancer patient. Br J Cancer 105:612-617.
12. Bell MS, Scullen P, McParlan D, et al. Neutropenic sepsis guidelines. Northen Ireland
Cancer Network, Belfast. 2010. P.1-11.
13. Paul M, Soares-Weiser K, Grozinsky S, Leibovici L. Beta-lactam versus beta-lactam-
aminoglycoside c ombination therapy in cancer patients with neutropaenia. Cochrane Database
Syst Rev 2003;(3):CD003038.
Paul M, Dickstein Y, Borok S, et al. Empirical antibiotics targeting Gram-positive bacteria for the
treatmentoffebrileneutropenicpatientswithcancer.CochraneDatabaseSystRev2014 14; 1:CD003914.
Kern WV, Marchetti O, Drgona L, et al. Oral antibiotics for fever in low-risk neutropenic patients
with cáncer: a double-blind, randomized, multicenter trial comparing single daily moxifloxacin
with twice daily ciprofloxacin plus amoxicillin/clavulanic acid combination therapy—EORTC
infectious diseases group trial XV. J Clin Oncol 2013 20; 31(9):1149-56.
Flower CR, Seidenfeld J, Bow EJ, et al. Antimicrobial prophylaxis and outpatient management
of fever and neutropenia in adults treated for malignancy: American Society of Clinical
Oncology clinical practice guideline. J Clin Oncol 2013; 31(3) :794-810.
1.
2.
3.
4.
5.
6.
7.
8.
9.
10.
11.
12.
13.
14.
15.
16.